Document is current

Any future updates will be listed below

Bevacizumab induces ferroptosis and enhances CD8+ T cell immune activity in liver cancer via modulating HAT1 and increasing IL-9

Crossref DOI link: https://doi.org/10.1038/s41401-024-01299-4

Published Online: 2024-05-17

Published Print: 2024-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark